|
India News Releases
|
(India.CityRegions.Com, October 04, 2017 ) ReportsWeb.com published “Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review H1 2017” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. Report provides latest news for the past three months. Original Content: Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Marburgvirus Infections - Pipeline Review, H1 2017, provides an overview of the Marburgvirus Infections (Cardiovascular) pipeline landscape.
Marburgvirus Infections is the irreversible necrosis of heart muscle secondary to prolonged ischemia. Symptoms include pain, fullness, and/or squeezing sensation of the chest, jaw pain, toothache, headache, shortness of breath, nausea, vomiting, and/or general epigastric discomfort, sweating, heartburn and/or indigestion, arm pain, upper back pain and general malaise (vague feeling of illness) . For more information about this report: http://www.reportsweb.com/marburgvirus-infections-marburg-hemorrhagic-fever-pipeline-review-h1-2017 Publisher's Pharmaceutical and Healthcare latest pipeline guide Marburgvirus Infections - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Marburgvirus Infections (Infectious Disease) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Report Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Marburgvirus Infections (Infectious Disease) . - The pipeline guide reviews pipeline therapeutics for Marburgvirus Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Marburgvirus Infections (Infectious Disease) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Marburgvirus Infections (Infectious Disease) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Marburgvirus Infections (Infectious Disease) Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001709451/sample - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Marburgvirus Infections (Infectious Disease) . - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Marburgvirus Infections (Infectious Disease) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. List of Tables
Number of Products under Development for Marburgvirus Infections (Marburg Hemorrhagic Fever) , H1 2017 Number of Products under Development by Companies, H1 2017 Number of Products under Development by Universities/Institutes, H1 2017 Products under Development by Companies, H1 2017 Products under Development by Universities/Institutes, H1 2017 Number of Products by Stage and Target, H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 Number of Products by Stage and Route of Administration, H1 2017 Number of Products by Stage and Molecule Type, H1 2017 Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline by Arno Therapeutics Inc, H1 2017 Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline by BioCryst Pharmaceuticals Inc, H1 2017 Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline by Emergent BioSolutions Inc, H1 2017 Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline by Fab'entech SA, H1 2017 Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline by GeoVax Labs Inc, H1 2017 Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline by Integrated BioTherapeutics Inc, H1 2017 Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline by Johnson & Johnson, H1 2017 Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline by Microbiotix Inc, H1 2017 Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline by NanoViricides Inc, H1 2017 Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline by Profectus BioSciences Inc, H1 2017 Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline by Rodos BioTarget GmbH, H1 2017 Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline by Sarepta Therapeutics Inc, H1 2017 Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline by Vaxart Inc, H1 2017 Marburgvirus Infections (Marburg Hemorrhagic Fever) - Dormant Projects, H1 2017 Marburgvirus Infections (Marburg Hemorrhagic Fever) - Discontinued Products, H1 2017
List of Figures
Number of Products under Development for Marburgvirus Infections (Marburg Hemorrhagic Fever) , H1 2017 Number of Products under Development by Companies, H1 2017 Number of Products under Development by Universities/Institutes, H1 2017 Number of Products by Top 10 Targets, H1 2017 Number of Products by Stage and Top 10 Targets, H1 2017 Number of Products by Top 10 Mechanism of Actions, H1 2017 Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017 Number of Products by Routes of Administration, H1 2017 Number of Products by Stage and Routes of Administration, H1 2017 Number of Products by Molecule Types, H1 2017 Number of Products by Stage and Molecule Types, H1 2017 Inquire before Buying at http://www.reportsweb.com/buy&RW0001709451/buy/3500 Contact Us: Call: +1-646-491-9876 Email: sales@reportsweb.com
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|
|
|
India RSS Feed Marketpalce
|
India News Headlines
Daily news from India: arts, business, culture, politics, science, technology & more.
Free Sales & Marketing Magazines
Get free publications about marketing, sales and customer relations management.
Submit RSS feed on India. Have your feed on news, products or services displayed under this marketpalce and have your feed on a full page updated daily.
|
|
India Business News by Major Cities
|
|
|
Listen to GroupWeb Radio
INDIA BUSINESS TV
|